Abstract
Background: Thiazole is widely investigated bioactive scaffold and dynamic tool in medicinal chemistry research. Significance of thiazole compounds are well documented as thiazole is an obligatory structure of number of currently available therapeutics. In spite of that, thiazole derivatives are endowed with myriad biological activities, such as antiviral, anticancer, antibacterial, antifungal, antimalarial, antiparkinsonian, anti-inflammatory activities and many more.
Methods: In recent past, different approaches have been introduced for synthesis of thiazole and related compounds. Intrinsic molecular interaction between newly synthesized thiazole compounds and plethora of drug targets/enzymes has rendered discovery of new drug molecules with advances in modes of action. A renewed interest in therapeutic use of thiazole derivatives has been seen among the prospective researchers as exemplified by influx of huge scientific articles and patents. Some important patents of anti-infective and anticancer interest have been addressed appropriately and are presented in tables.
Results: This review paper is a contemporary approach on therapeutic/applications of thiazole derivatives by summarizing important patents filed from 2000-2017. The main focus of these patents is on anti-infective and anticancer potential of thiazole based compounds.
Conclusion: These approaches may provide valuable information for the further design of more active biological agents through various modifications and derivatizations.
Keywords: Thiazole, patents, biological activities, antifungal, antidiuretic, leinamycin.
Graphical Abstract
[1]
Shah, J.J.; Mohanraj, K. Comparison of conventional and microwave-assisted synthesis of benzotriazole derivatives. Indian J. Pharm. Sci., 2014, 76(1), 46-53.
[2]
Sharma, P.C.; Jain, A.; Jain, S.; Pahwa, R.; Yar, M.S. Ciprofloxacin: Review on developments in synthetic, analytical, and medicinal aspects. J. Enzyme Inhib. Med. Chem., 2010, 25(4), 577-589.
[3]
Kharb, R.; Yar, S.M.; Sharma, P.C. New insights into chemistry and anti-infective potential of triazole scaffold. Curr. Med. Chem., 2011, 18(21), 3265-3297.
[4]
Eicher, T.; Hauptmann, S.; Speicher, A. The Chemistry of Heterocycles: Structure, reactions, syntheses, and applications, 3rd ed; Wiley-VCH: Weinheim, 2012.
[5]
Abele, E.; Abele, R.; Lukevics, E. Oximes of five membered heterocyclic compounds with three and four heteroatoms. Chemistry of Heterocyclic Compdounds; Springer: New York, 2007.
[6]
Ayati, A.; Emami, S.; Asadipour, A.; Shafiee, A.; Foroumadi, A. Recent applications of 1, 3-thiazole core structure in the identification of new lead compounds and drug discovery. Eur. J. Med. Chem., 2015, 97, 699-718.
[7]
Saini, A.; Bansal, K.K.; Sharma, P.C. Synthesis of some thiazole clubbed possible antimicrobial and anthelmintic agents. Ind. J. Het. Chem., 2016, 25(3-4), 303-310.
[8]
Dawood, K.M.; Eldebss, T.M.A.; El-Zahabi, H.S.A.; Yousef, M.H. Synthesis and antiviral activity of some new bis-1,3-thiazole derivatives. Eur. J. Med. Chem., 2015, 102, 266-276.
[9]
Bhalerao, M.B.; Dhumal, S.T.; Deshmukh, A.R.; Nawale, L.U.; Khedkar, V.; Sarkar, D.; Mane, R.A. New bithiazolyl hydrazones: Novel synthesis, characterization and antitubercular evaluation. Bioorg. Med. Chem. Lett., 2017, 27, 288-294.
[10]
Bueno, J.M.; Carda, M.; Crespo, B.; Cunat, A.C.; de Cozar, C.; Leon, M.L.; Marco, J.A.; Roda, N.; Sanz-Cervera, J.F. Design, synthesis and antimalarial evaluation of novel thiazole derivatives. Bioorg. Med. Chem. Lett., 2016, 26, 3938-3944.
[11]
Zelisko, N.; Atamanyuk, D.; Vasylenko, O.; Grellier, P.; Lesyk, R. Synthesis and antitrypanosomal activity of new 6,6,7-trisubstituted thiopyrano[2,3-d][1,3]thiazoles. Bioorg. Med. Chem. Lett., 2012, 22, 7071-7074.
[12]
Khan, K.M.; Qurban, S.; Salar, U.; Taha, M.; Hussain, S.; Perveen, S.; Hameed, A.; Ismail, N.H.; Riaz, M.; Wadood, A. Synthesis, in vitro α-glucosidase inhibitory activity and molecular docking studies of new thiazole derivatives. Bioorg. Chem., 2016, 68, 245-258.
[13]
Kamblea, R.D.; Meshramb, R.J.; Hesea, S.V.; Moreb, R.A.; Kambleb, S.S.; Gaccheb, R.N.; Dawanea, B.S. Synthesis and in silico investigation of thiazoles bearing pyrazoles derivatives as anti-inflammatory agents. Comput. Biol. Chem., 2016, 61, 86-96.
[14]
Flood, A.; Trujillo, C.; Sanchez-Sanz, G.; Kelly, B.; Muguruza, C.; Callado, L.F.; Rozas, I. Thiophene/thiazole-benzene replacement on guanidine derivatives targeting α2-adrenoceptors. Eur. J. Med. Chem., 2017, 138, 38-50.
[15]
Abbas, S.; Nasir, H.H.; Zaib, S.; Ali, S.; Mahmood, T.; Ayub, K.; Tahir, M.N.; Iqbal, J. Carbonic anhydrase inhibition of schiff base derivative of imino-methyl-naphthalen-2-ol: Synthesis, structure elucidation, molecular docking, dynamic simulation and density functional theory calculations. J. Mol. Struct., 2018, 1156, 193-200.
[16]
Turan-Zitouni, G.; Altıntop, M.D.; Ozdemir, A.; Kaplancikli, Z.A.; Ciftci, G.A.; Temel, H.E. Synthesis and evaluation of bis-thiazole derivatives as new anticancer agents. Eur. J. Med. Chem., 2016, 107, 288-294.
[17]
Newman, D.J.; Cragg, G.M.; Snader, K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod., 2003, 66, 1022-1037.
[18]
Rouf, A.; Tanyeli, C. Bioactive thiazole and benzothiazole derivatives. Eur. J. Med. Chem., 2015, 97, 911-927.
[20]
Pasqualotto, A.C.; Thiele, K.O.; Goldani, L.Z. Novel triazole antifungal drugs: Focus on isavuconazole, ravuconazole and albaconazole. Curr. Opin. Investig. Drugs, 2010, 11(2), 165-174.
[21]
Borelli, C.; Schaller, M.; Niewerth, M.; Nocker, K.; Baasner, B.; Berg, D.; Tiemann, R.; Tietjen, K.; Fugmann, B.; Lang-Fugmann, S.; Korting, H.C. Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi. Chemother., 2008, 54(4), 245-259.
[22]
Lamb, H.M.; Ormrod, D.; Scott, L.J.; Figgitt, D.P. Ceftriaxone: An update of its use in the management of community-acquired and nosocomial infections. Drugs, 2002, 62(7), 1041-1089.
[24]
Medina, T.; Amaria, M.N.; Jimeno, A. Dabrafenib in the treatment of advanced melanoma. Drugs Today (Barc), 2013, 49(6), 377-385.
[25]
Tricot, G.; Jayaram, H.N.; Weber, G.; Hoffman, R. Tiazofurin: Biological effects and clinical uses. Int. J. Cell Cloning, 1990, 8(3), 161-170.
[26]
Igual-Adell, R.; Oltra-Alcaraz, C.; Soler-Company, E.; Sanchez-Sanchez, P.; Matogo-Oyana, J.; Rodriguez-Calabuig, D. Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis. Expert Opin. Pharmacother., 2004, 5(12), 2615-2619.
[27]
Linington, R.G.; Gonzalez, J.; Urena, L.D.; Romero, L.I.; Ortega-Barria, E.; Gerwick, W.H. Venturamides A and B: Antimalarial constituents of the panamanian marine Cyanobacterium Oscillatoria sp. J. Nat. Prod., 2007, 70(3), 397-401.
[28]
Scatena, R.; Bottoni, P.; Pontoglio, A.; Mastrototaro, L.; Giardina, B. Glycolytic enzyme inhibitors in cancer treatment. Expert Opin. Investig. Drugs, 2008, 17(10), 1533-1545.
[29]
Sharma, P.C.; Bansal, K.K.; Deep, A.; Pathak, M. Benzothiazole derivatives as potential anti-infective agents. Curr. Top. Med. Chem., 2017, 17(2), 208-237.
[30]
Sharma, P.C.; Sinhmar, A.; Sharma, A.; Rajak, H.; Pathak, D.P. Medicinal significance of benzothiazole scaffold: An insight view. J. Enzyme Inhib. Med. Chem., 2013, 28(2), 240-266.
[31]
Zwick, E.; Bange, J.; Ullrich, A. Receptor tyrosine kinase signalling as a target for cancer intervention strategies. Endocr. Relat. Cancer, 2001, 8(3), 161-173.
[32]
Munagala, R.; Aqil, F.; Gupta, R.C. Promising molecular targeted therapies in breast cancer. Ind. J. Pharmacol., 2011, 43(3), 236-245.
[33]
Wang, G.; Jiang, Q.; Zhong, Q.; Zhang, Q.; Zheng, S. Antimigration
and anti-invasion thiazole analogs for treatment of cellular
proliferative disease. U.S. Patent 9,650,369, B2, May 16, 2017.
[34]
Nan, F.; Li, J.; Xie, X.; Gong, C.; Zhou, Y.; Chai, H.; Zhang, Y.; Su, M. 2,2′-tandem dithiazole compound, preparation method
thereof, and use thereof. U.S. Patent 9,643,941, B2, May 9, 2017.
[35]
Rocchi, S.; Ballotti, R.; Benhida, R.; Cerezo, M.; Duca, M.; Joly, J. Benzene sulfonamide thiazole compounds. U.S. Patent 9,567,310,
B2, Feb 14, 2017.
[36]
Karra, S.R.; Staehle, W.; Staub, E.; Wucherer-Plietker, M. Thiazole
derivatives. U.S. Patent 9,249,114, B2, Feb 2, 2016.
[37]
Luthra, P.M.; Mishra, C. (4E)-4-(4-substituted benzylideneamino)-
2, 3-dihydro-3-substituted-2-thioxothiazole-5-carbonitriles as
A2AR antagonist and process for preparation thereof. U.S. Patent
9,518,033, B2, Dec 13, 2016.
[38]
Huby, N.J.S.; Lopez-Tapia, F.J.; Sung-Sau, S. Thiazole derivatives
as inhibitors of Bruton's tyrosine kinase. U.S. Patent 9,359,345, B2,
Jun 7, 2016.
[39]
Albert, E.; Bacque, E.; Nemecek, C.; Ugolini, A.; Wentzler, S. 6-
Triazolopyridazine sulfanyl benzothiazole derivatives as Met inhibitors.
U.S. Patent 9,321,777, B2, Apr 26, 2016.
[40]
Ham, S.W. 2-Aminothiazole derivative and anti cancer composition
comprising same as active ingredient. U.S. Patent 9,457,015,
B2, Oct 4, 2016.
[41]
Jiaang, W.; Hsu, T.; Lin, W.; Chao, Y. Pyrazole compounds and
thiazole compounds as protein kinases inhibitors. U.S. Patent
9,255,072, B2, Feb 9, 2016.
[42]
Wang, G.; Jiang, Q.; Zhong, Q.; Zhang, Q.; Zheng, S. Antiinvasion
anti-migration and thiazole analogs for treatment of cellular
proliferative disease. U.S. Patent 0,274,714, A1, Oct 1, 2015.
[43]
Lajeunesse, J.; DiMarco, J.D.; Galella, M.; Chidambaram, R. Process
for preparing 2-aminothiazole-5-aromatic carboxamides as
kinase inhibitors. U.S. Patent 8,680,103, B2, Mar 25, 2014.
[44]
Dumble, M.; Gilmer, T.; Kumar, R.; Lebowitz, P.F.; Morris, S.R.; Laquerre, S. Combination of a B-Raf inhibitor: N-3-[5-(2-amino-
4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-
fluorophenyl 2,6-difluorobenzenesulfonamide and the Akt inhibitor:
N-(1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl-5-chioro-4-
(4-chioro-1-methyl-1H-pyrazol-s-yl)-2-10 thiophenecarboxamide
useful in the treatment of cancer. U.S. Patent 8,796,298, B2, Aug 5, 2014.
[45]
Mortimore, M.; Golec, J.; Davis, C.; Robinson, D.; Studley, J. Thiazoles and pyrazoles valuable as kinase inhibitors. U.S. Patent
8,785.444, B2, Jul 22, 2014.
[46]
Beroza, P.P.; Damodaran, K.V.; Laborde, E.; Thomas, W. Substituted
thiazole derivatives as VEGFR2 kinase inhibitors. U.S. Patent
0,184,280, A1, July 18, 2013.
[47]
Song, J. Method of cancer treatment with 2-(1H-indole-3-
carbonyl)-thiazole-4 carboxylic acid methyl ester. U.S. Patent
0,338,201, A1, Dec 19, 2013.
[48]
Gerald, W.S.J.; Richards, M.; Cheng, C.C.; Huang, X. Thiazole
carboxamide derivatives and their use to treat cancer. U.S. Patent
8,394,960, B2, Mar 12, 2013.
[49]
Uoto, K.; Sugimoto, Y.; Naito, H.; Miyazaki, M.; Yoshida, K.; Aonuma, M. Imidazothiazole derivatives having a proline ring
structure having anti-tumor activity by inhibition of murine double
minute 2 (mdm2) or their salt. U.S. Patent 8,404,691, B2, Mar 26, 2013.
[50]
Irie, T.; Sawa, M.; Ito, S.; Tanaka, C.; Ro, S.G.; Park, C.H. The
novel invention inhibited the CDC7 protein kinase activity, and
control of cell proliferation. U.S. Patent 8,119,812, B2, Feb 21, 2012.
[51]
An, H.; Xi, B.; Abassi, Y.; Wang, X.; Xu, X. Imidazothiazolechalcone
derivatives as potential heterocyclic compounds and their
anticancer agents. U.S. Patent 8,252,822, B2, Aug 28, 2012.
[52]
Mortimore, M.; Golec, J.; Davis, C.; Robinson, D.; Studley, J. Thiazoles and pyrazoles useful as kinase inhibitors. U.S. Patent
8,268,811, B2, Sep 18, 2012.
[53]
Irie, T.; Sawa, M.; Ito, S.; Tanaka, C.; Ro, S.G. Park. H.C. Thiazolidinone
derivative. U.S. Patent 0,190,299, A1, Aug 4, 2011.
[54]
Mortimore, M.P.; Davis, C.J.; Golec, J.M.C.; Studley, J.; Robinson, D.D. Thiazoles and pyrazoles useful as kinase inhibitors. U.S. Patent
0,060,013, A1, Mar. 10, 2011.
[55]
Romo, D.; Liu, J.; Choi, N.S.; Shi, Z.; Low, W.; Dang, Y.; Schneider-Poetsch, T. Thiazole derivatives as anticancer agents and their
use. U.S. Patent 7,737,134, B2, Jun 15, 2010.
[56]
Miller, D.D.; Dalton, J.T.; Gududuru, V.; Hurh, E. Thiazolidinones
amides, thiazolidine carboxylic acidamides, and serine amides including
polyamine conjugates thereof, as selective anti cancer
agents. U.S. Patent 7,662,842, B2, Feb 16, 2010.
[57]
Lajeunesse, J.; DiMarco, J.D.; Galella, M.; Chidambaram, R. Process
for preparing 2-aminothiazole-5-aromatic carboxamides as
kinase inhibitors. U.S. Patent 7,491,725, B2, Feb 17, 2009.
[58]
Cassin, M.; Colella, G.; Munari, S.D.; Grugni, M. The invention
describes the use of compounds for the preparation of pharmaceutical
compositions for the treatment of pathologies in which inhibition
of the interaction between HIF-1α and p300 is beneficial, in
particular as antiangiogenic medicaments for the therapy of solid
tumors. U.S. Patent 0,261,980, A1, Oct 23, 2008.
[59]
Courtney, S.M.; Hay, P.A.; Scopes, D.I.C. Novel furanthiazole
derivatives which are useful as inhibitors of heparanase. U.S. Patent
7,326,727, B2, Feb 5, 2008.
[60]
Noronha, G.; Cao, J.; Zeng, B.; Mak, C.C.; McPherson, A.; Renick, J.; Pathak, V.P.; Chow, C.; Palanki, M.; Soll, R.M.; Lohse, D.L.; Hood, J.D.; Dneprovskaia, E. Thiazole inhibitors targeting resistant
kinase mutations. U.S. Patent 0,161,645, A1, Jul 12, 2007.
[61]
Siemeister, G.; Briem, H.; Schulze, V.; Eis, K.; Wortmann, L.; Schwede, W.; Schneider, H.; Eberspaecher, V.; Stumpp, H.H. Inhibitors
of polo-like kinases; (4,4-Dimethyl-4,5-dihydro-oxazol-2-
yl)-[3-ethyl-4-oxo-5-[1-[3-(2-pyrrolidin-1-yl-ethyl)-phenylamino]-
meth-(E/Z)-ylidene]-thiazolidin-(2-(E or Z))-ylidene]-acetonitrile;
cancer, auto-immune diseases, cardiovascular diseases. U.S. Patent
0,037,862, A1, Feb 15, 2007.
[62]
Knox, P.; O’Sullivan, M.; Lentfer, H. Piperidinyl-thiazole carboxylic
acid derivatives as angiogenesis inhibitors. U.S. Patent
0,135,501, A1, Jun 22, 2006.
[63]
Chu, S.S.; Alegria, L.A.; Bleckman, T.M.; Chong, W.K.M.; Duvadie, R.K.; Li, L.; Reich, S.H.; Romines, W.H.; Wallace, M.B.; Yang, Y. Thiazole benzamide derivatives and pharmaceutical compositions
for inhibiting cell proliferation. U.S. Patent 6,720,346,
B2, Apr 13, 2004.
[64]
Pevarello, P.; Amici, R.; Traquandi, G.; Villa, M.; Vulpetti, A.; Isacchi, A. 2-Ureido-thiazole derivatives, process for their preparation,
and their use as antitumor agents. U.S. Patent 6,863,647, B2,
Mar 8, 2005.
[65]
Pfahl, M.; Tachdjian, C.; Wiemann, T.; Cow, C.; Spruce, L.; Giachino, A.; Kaspar, A.; Zapf, J. Benzimidazole, benzoxazole, and
benzothiazole derivatives for the treatment of cancer and other diseases.
U.S. Patent 0,014,767, A1, Jan 20, 2005.
[66]
Chu, S.S.; Alegria, L.A.; Bleckman, T.M.; Chong, W.K.M.; Duvadie, R.K.; Li, L.; Reich, S.H.; Romines, W.H.; Wallace, M.B.; Yang, Y. Thiazole benzamide derivatives and pharmaceutical compositions
for inhibiting cell proliferation. U.S. Patent 6,720,346,
B2, Apr 13, 2004.
[67]
Pevarello, P.; Amici, R.; Villa, M.; Salom, B.; Vulpetti, A.; Varasi, M. Arylmethyl-carbonylamino thiazole derivatives and their use as
antitumor agents. U.S. Patent 6,784,198, B1, Aug 31, 2004.
[68]
Yue, E.W. Novel 3-(2, 4-dimethylthiazol-5-yl) indeno [1, 2-c]
pyrazol-4-one derivatives which are useful as cyclin dependent
kinase (cdk) inhibitors. U.S. Patent 6,706,718, B2, Mar 16, 2004.
[69]
Cochran, J.; Nanthakumar, S.; Harrington, E.; Wang, J. Thiazole
compounds useful as inhibitors of protein kinase. U.S. Patent
6,762.179, B2, Jul 13, 2004.
[70]
Chong, W.K.M.; Duvadie, R.K. Pyrazole-thiazole compounds,
pharmaceutical compositions containing them. U.S. Patent US
6,566,363, B2, May 20, 2003.
[71]
Duncia, J.J.V.; Gardner, D.S.; Santella, J.B. N-Adamant-1-y1-N1-
[4-chlorobenzothiazol-2-yl] urea useful in the treatment of inflammation
and as an anticancer radiosensitizing agent. U.S. Patent
6,214,851, B1, Apr 10, 2001.
[72]
Pevarello, P.; Amici, R.; Villa, M.; Salom, B.; Vulpetti, A.; Varasi, M. Arylmethyl-carbonylamino thiazole derivatives, process for
their preparation, and their use as antitumor agents. U.S. Patent
6,114,365, A, Sep 5, 2000.
[73]
Kharb, R.; Sharma, P.C.; Yar, M.S. Pharmacological significance of triazole scaffold. J. Enzyme Inhib. Med. Chem., 2011, 26(1), 1-21.
[74]
Huang, X.; Zhao, N.; Zhang, K. Extracellular enzymes serving as virulence factors in nematophagous fungi involved in infection of the host. Res. Microbiol., 2004, 155, 811-816.
[75]
Cushman, M.S.; Seleem, M.; Mayhoub, A.S. Antimicrobial substituted
thiazoles and methods of use. U.S. Patent 9,801,861, B2, Oct
31, 2017.
[76]
Cushman, M.S.; Seleem, M.; Mayhoub, A.S. Antimicrobial substituted
thiazoles and methods of use. U.S. Patent 9,353,072, B2, May
31, 2016.
[77]
You, J.C.; Han, G.H.; Lee, C.H.; Song, D.N.; Chung, K.H. Method
for preparing the novel rhodanine derivatives, and a pharmaceutical
composition for the prevention or treatment of AIDS containing the
rhodanine derivatives as active ingredients. U.S. Patent 8,759,536,
B2, Jun 24, 2014.
[78]
Fublein, M.; Bretschneider, T.; Fischer, R.; Jeschke, P.; Kohler, A.; Kluth, J.; Muhlthau, F.A.; Voerste, A.; Sato, Y. Thiazole derivatives
as pesticides. U.S. Patent 8,686,156, B2, Apr 1, 2014.
[79]
Felise, H.B.; Miller, S.I.; Kline, M.I. 5-Substituted-2-iminothiazolidinone
compounds and their use as inhibitors of bacterial
infection. U.S. Patent 0,039,849, A1, Feb 17, 2011.
[80]
O’Sullivan, A.C.; Gsell, L.; Naef, R.; Senn, M.; Pitterna, T.; Wadsworth, D.J. Process for the preparation of 2-chloro-5-
chloromethyl-thiazole. U.S. Patent 8,013,167, B1, Sep 6, 2011.
[81]
Eggenweiler, H.; Wolf, M. Thiazole derivatives as phosphodiesterase
IV inhibitors. U.S. Patent 7,790,723, B2, Sep 7, 2010.
[82]
Surolia, A.; Surolia, N.; Kumar, G.; Chhibber, M.; Parasuraman, P.; Kumar, S.; Shanna, S.K.; Sharma, S. 2-Thioxothiazolidin-4-one
compounds and compositions as antimicrobial and antimalarial
agents targeting enoyl-ACP reductase of type II fatty acid. U.S.
Patent 0,051,445, A1, Feb 28, 2008.
[83]
Rapold, T.; Seifert, G.; Senn, M. Process for the manufacture of
thiazole derivatives with pesticidal activity. U.S. Patent 6,861,522,
B2, Mar 1, 2005.
[84]
Coppola, K. Process for the preparation of thiazole derivatives.
U.S. Patent 6,566,530 B2, May 20, 2003.
[85]
Yu, D.W.T.; Macina, O.T.; Sircar, I.; Sircar, J.C.; Riviello, C.M. Pyridyl substituted thiazole. U.S. Patent 0,000,178, A1, Apr 5, 2001.
[86]
Sharma, P.K.; Swonhney, S.N.; Gupta, A.; Singh, G.B.; Bani, S. Synthesis of some novel 2,4-disubstituted thiazoles. Indian J. Chem., 1998, 37B, 371-375.
[87]
Gupta, V.; Kant, V. A review on biological activity of imidazole and thiazole moieties and their derivatives; Sci. Inter, 2013, pp. 253-260.
[88]
Kolbe, L.; Scherner, C.; Breitkreutz, S.; Woehrmann, M.; Mann, T.; Gerwat, W.; Schlaeger, T. Alkylamidothiazoles, cosmetic or
dermatological preparations containing said alkylamidothiazoles,
and use thereof to combat or prevent undesired pigmentation of the
skin. U.S. Patent 9,533,963, B2, Jan 3, 2017.
[89]
Jiang, F.; Zhou, P.; Chen, J.; Wang, Y.; Cao, B.; Yan, J. 2-
Aminothiazole derivatives and methods of preparing and a method
using the same. U.S. Patent 9,771,340, B2, Sep 1, 2013.
[90]
Alcalde-Pais, M.D.E.; Fernández, J.L.D.; Mesquida-Estevez, M.D.N.; Paloma-Romeu, L. Imidazo[2,1-b]thiazole derivatives,
their preparation and use as medicaments. U.S. Patent 9,617,281,
B2, Apr 11, 2017.
[91]
Machacek, M.R.; Romeo, E.T.; Northrup, A.B.; Altman, M.D. Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors.
U.S. Patent 9,783,531, B2, Oct 10, 2017.
[92]
Griffioen, G.; Cecere, G.; Nettekoven, M.; Princen, K.; Ratni, H.; Rogers-Evans, M.; Vifian, W. Piperazine thiazole derivatives useful
in the treatment of tauopathies, such as Alzheimer's disease.
U.S. Patent 9,808,456, B2, Nov 7, 2017.
[93]
Kokotos, G.; Johansen, B.; Magrioti, V.; Tsakos, M. 2-Oxothiazole
compounds and method of using same for chronic inflammatory
disorders. U.S. Patent 9,597,318, B2, Mar 21, 2017.
[94]
Aramini, A.; Bianchini, G.; Brandolini, L.; Beccari, A.; Lillini, S.; Nano, G. 2-Aryl-4-hydroxy-1,3-thiazole derivatives useful as
trpm8-inhibitors in treatment of neuralgia, pain and asthma. U.S.
Patent 0,190,678, A1, Jul 6, 2017.
[95]
Mann, T.; Scherner, C.; Kolbe, L.; Batzer, J. Combinations of
alkylamidothiazoles and preservatives. U.S. Patent 9,610,234, B2,
Apr 4, 2017.
[96]
Thiele, D.J.; Neef, D.W.; Mendoza, J.S. Substituted 1, 3-thiazoles
as heat shock transcription factor 1 activators. U.S. Patent
9,447,058, B2, Sep 20, 2016.
[97]
Dasgupta, R.; Gonsalves, F. Oxazole and thiazole compounds as β-
catenin modulators and uses thereof. U.S. Patent 9,433,611, B2,
Sep 6, 2016.
[98]
Arrington, K.L.; DuBois, B.; Debenham, J.S.; Liu, P.; Northrup, A.B.; Szewczyk, J.W.; Wang, L.; Wang, M. Thiazole-substituted
aminopyrimidines as spleen tyrosine kinase inhibitors. U.S. Patent
9,499,534, B2, Nov 22, 2016.
[99]
Kolbe, L.; Scherner, C. Cosmetic or dermatological preparations
with content of one or more thiazole derivates. U.S. Patent
8,920,785, B2, Dec 30, 2014.
[100]
Zhao, G.; Xu, W.; Wang, Y.; Tang, L.; Li, Y.; Zou, M.; Liu, W.; Shao, H.; Tan, C.; Liu, P. Amide thiazole derivative, preparation
method and uses thereof. U.S. Patent 8,481,577, B2, Jul 9, 2013.
[101]
Ryu, S.E.; Kim, S.J.; Jeong, D.G.; Lee, S.H.; Jung, S.K.; Kim, H.M.; Park, S.K.; Lee, K.H.; Lee, C.W.; Choi, J.K.; Ahn, J.H. Rhodanine
derivatives, a method for the preparation thereof, and a pharmaceutical
composition containing the same. U.S. Patent 8,148,541, B2,
Apr 3, 2012.
[102]
Potluri, V.K.; Das, S.K.; Sasmal, P.K.; Iqbal, J.; Misra, P.; Chakrabarti, R.; Talwar, R. Thiazole derivatives as AMPK activator. U.S.
Patent 8,080,668, B2, Dec 20, 2011.
[103]
Old, W.D. Therapeutic substituted thiazolidinones, oxazolidinones,
and related compounds. U.S. Patent 8,003,678, B2, Aug 23, 2011.
[104]
Lange, J.H.M.; Kruse, C.G.; Herremans, A.H.J.; Stuivenberg, H.H.V.; Dijksman, J.A.R.; McCreary, A.C. Thiazole derivatives
having CBi-antagonistic, agonistic or partial agonistic activity. U.S.
Patent 7,342,032, B2, Mar 11, 2008.
[105]
Miller, M.T.; Ruah, S.S.H.; Grootenhuis, P.D.J.; Hamilton, M. Thiazoles and oxazoles useful as modulators of ATP-binding cassette
transporters. U.S. Patent 7,407,976, B2, Aug 5, 2008.
[106]
Schaefer, B.; Haunert, F.; Goetz, N. Preparation of 2-aminothiazole-
5-carboxylic-acid derivatives. U.S. Patent 7,408,069, B2,
Aug 5, 2008.
[107]
Inoue, T.; Tojo, T.; Morita, M. Thiazole derivatives having Vap-1
inhibitory activity. U.S. Patent 0,254,931, A1, Nov 1, 2007.
[108]
Chen, J.P.; Suzuki, K. Thiazole- and imidazole-fused phenanthroline
molecules in organic light-emitting devices. U.S. Patent
7,179,542, B2, Feb 20, 2007.
[109]
Wagle, D.; Gall, M.; Bell, S.C.; Lavoie, E.J. Method for treating
fibrotic diseases or other indications utilizing thiazole, oxazole and
imidazole compounds. U.S. Patent 7,026,342, B2, Apr 11, 2006.
[110]
Sierra, M.L. Substituted oxazoles and thiazoles as HPPAR alpha
agonists. U.S. Patent 7,091,225, B2, Aug 15, 2006.
[111]
Wagle, D.; Vasan, S.; Egan, J. Thiazole, imidazole and oxazole
compounds and treatments of disorders associated with protein aging.
U.S. Patent 6,960,605, B2, Nov 1, 2005.
[112]
Uckun, F.M.; Venkatachalam, T.K. Adamantyl thiazole thioureas.
U.S. Patent 6,960,606, B2, Nov 1, 2005.
[113]
Ueno, A.; Nagao, R.; Watanabe, R.; Ohta, H.; Yagi, M. soxazole
and thiazole compounds and use thereof as medicine. U.S. Patent
6,964,975, B2, Nov 15, 2005.
[114]
Tsutsumi, H.; Tabuchi, S.; Akahane, A.; Yasuda, H.; Omori, H.; Temmaru, K.; Zanka, A. Thiazole derivative and pharmaceutical
use thereof. U.S. Patent 0,004,134, A1, Jan 6, 2005.
[115]
Sanner, M.A.; Helal, C.J.; Cooper, C.B. Thiazole derivatives. U.S.
Patent 6,720,427, B2, Apr 13, 2004.
[116]
Hogenkamp, D.; Upasani, R.; Nguyen, P. Aryl substituted pyrazoles,
imidazoles, oxazoles, thiazoles and pyrroles, and the use
thereof. U.S. Patent 6,737,418, B2, May 18, 2004.
[117]
Wenderoth, B.; Strauss, R.; Lonchampt, J. Antifreeze concentrates
based on dicarboxylic acids, molybdate and triazoles or thiazoles,
and coolant compositions comprising them. U.S. Patent 6,802,988,
B1, Oct 12, 2004.
[118]
Dhanoa, D.S. E- Ryan, D.; Deckman, I.; Saplenza, A. Substituted
thiazoles and the use thereof as inhibitors of plasminogen activator
inhibitor-1. U.S. Patent 6,586,453, B2, Jul 1, 2003.
[119]
Bar, T.; Ulrich, W. Thiazole derivatives with phosphodiesteraseinhibiting
action. U.S. Patent 6,011,037, A, Jan 4, 2000.
[120]
Mathvink, R.J.; Parmee, E.R.; Tolman, S.; Weber, A.E. Thiazole
benzenesulfonamides as β3 agonists for treatment of diabetes and
obesity. U.S. Patent 6,011,048, A, Jan 4, 2000.
[121]
Bar, T.; Ulrich, W. (2, 3-Dihydrobenzofuranyl) thiazoles as phosphodiesterase
inhibitors. U.S. Patent 6,043,263, A, Mar 28, 2000.
[122]
Yoo, H.Y.; Chung, K.J.; Chai, J.P.; Chang, M.S.; Kim, S.G.; Choi, W.S.; Kim, Y.H.; Chun, K.; Chung, Y.K.; Kim, Y.H.; Paek, J.H.; Seo, K.H.; Kang, D.P. Heterocycle-fused thiazole derivatives. U.S.
Patent 6,043,373, A, Mar 28, 2000.
[123]
Meszaros, L.; Schrimpf, H.; Pfitzner, K. Glycol based antifreeze
concentrates inhibited with monocarboxylic acid salts together with
hydrocarbon triazoles and/or –thiazoles. U.S. Patent 6,080,331, A,
Jun 27, 2000.
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Analytical Chemistry
Current Computer-Aided Drug Design
Current Cancer Drug Targets
Combinatorial Chemistry & High Throughput Screening
Current Cancer Therapy Reviews
Current Diabetes Reviews
Current Drug Safety
Current Drug Targets
Related Books
Drug Addiction Mechanisms in the Brain
Botanicals and Natural Bioactives: Prevention and Treatment of Diseases
Software and Programming Tools in Pharmaceutical Research
Objective Pharmaceutics: A Comprehensive Compilation of Questions and Answers for Pharmaceutics Exam Prep
Biotechnology and Drug Development for Targeting Human Diseases
Biosurfactants: A Boon to Healthcare, Agriculture & Environmental Sustainability
Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems
Frontiers in Computational Chemistry
Enzymatic Targets for Drug Discovery Against Alzheimer's Disease
Advances in Dye Degradation
Article Metrics
80
4
